The NK-Cell Lymphoma Drug Pipeline and Market Forecast
Natural Killer (NK)-cell lymphoma is a rare and aggressive cancer that originates in NK cells, a key component of the immune system responsible for eliminating infected or cancerous cells. Among its subtypes, extranodal NK/T-cell lymphoma, nasal type, is the most common. Due to the disease’s aggressive nature, treatment options remain limited, making the NK-Cell Lymphoma Therapeutics...
0 Kommentare 0 Anteile 854 Ansichten 0 Vorschau